Evidence map›Paper›PMID 36328987›Full record

ArticleCancer communications (London, England)2023

circCAPRIN1 interacts with STAT2 to promote tumor progression and lipid synthesis via upregulating ACC1 expression in colorectal cancer.

Yufei Yang, Dakui Luo, Yang Shao, Zezhi Shan, Qi Liu, Junyong Weng, Weijing He, Ruoxin Zhang, Qingguo Li, Ziliang Wang and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cancer communications (London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Insights Into circRNA-Mediated Lipid Metabolism in Cancer Progression.Journal of cellular and molecular medicine · 2026
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Recent advances of circular RNAs in gastrointestinal cancer.World journal of clinical oncology · 2025
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Yufei YangDepartment of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.
Dakui LuoDepartment of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.
Yang ShaoDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, P. R. China.
Zezhi ShanDepartment of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.
Qi LiuDepartment of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.
Junyong WengDepartment of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.
Weijing HeDepartment of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.
Ruoxin ZhangDepartment of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.
Qingguo LiDepartment of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.
Ziliang WangShanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071, P. R. China.
Xinxiang LiDepartment of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.ORCID 0000-0002-2354-4735
Shanghai Medical College of Fudan University · CNShanghai University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCircular RNAs (circRNAs) generated by back-splicing of precursor mRNAs (pre-mRNAs) are often aberrantly expressed in cancer cells. Accumulating evidence has revealed that circRNAs play a critical role in the progression of several cancers, including colorectal cancer (CRC). However, the current understandings of the emerging functions of circRNAs in CRC lipid metabolism and the underlying molecular mechanisms are still limited. Here, we aimed to explore the role of circCAPRIN1 in regulating CRC lipid metabolism and tumorigenesis.

methodscircRNA microarray was performed with three pairs of tumor and non-tumor tissues from CRC patients. The expression of circRNAs were determined by quantitative PCR (qPCR) and in situ hybridization (ISH). The endogenous levels of circRNAs in CRC cells were manipulated by transfection with lentiviruses overexpressing or silencing circRNAs. The regulatory roles of circRNAs in the occurrence of CRC were investigated both in vitro and in vivo using gene expression array, RNA pull-down/mass spectrometry, RNA immunoprecipitation assay, luciferase reporter assay, chromatin immunoprecipitation analysis, and fluorescence in situ hybridization (FISH).

resultsAmong circRNAs, circCAPRIN1 was most significantly upregulated in CRC tissue specimens. circCAPRIN1 expression was positively correlated with the clinical stage and unfavorable prognosis of CRC patients. Downregulation of circCAPRIN1 suppressed proliferation, migration, and epithelial-mesenchymal transition of CRC cells, while circCAPRIN1 overexpression had opposite effects. RNA sequencing and gene ontology analysis indicated that circCAPRIN1 upregulated the expressions of genes involved in CRC lipid metabolism. Moreover, circCAPRIN1 promoted lipid synthesis by enhancing Acetyl-CoA carboxylase 1 (ACC1) expression. Further mechanistic assays demonstrated that circCAPRIN1 directly bound signal transducer and activator of transcription 2 (STAT2) to activate ACC1 transcription, thus regulating lipid metabolism and facilitating CRC tumorigenesis.

conclusionsThese findings revealed the oncogenic role and mechanism of circCAPRIN1 in CRC. circCAPRIN1 interacted with STAT2 to promote CRC tumor progression and lipid synthesis by enhancing the expression of ACC1. circCAPRIN1 may be considered as a novel potential diagnostic and therapeutic target for CRC patients.

Indexed as

Acetyl-CoA CarboxylaseColorectal NeoplasmsRNA, CircularSTAT2 Transcription FactorCarcinogenesisCell Cycle ProteinsHumansIn Situ Hybridization, FluorescenceLipidsNeoplastic ProcessesACACA protein, humanAcetyl-CoA CarboxylaseCAPRIN1 protein, humanCell Cycle ProteinsLipidsRNA, CircularSTAT2 protein, humanSTAT2 Transcription FactorACC1circCAPRIN1circRNAcolorectal cancerlipid metabolismSTAT2

Identifiers

PMID36328987
PMCPMC9859733
OpenAlexW4308073325

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.